SynDevRx's Unattributed Round

SynDevRx raised a round of funding on March 21, 2018.

SynDevRx has developed a technology that increases the activity and safety of small molecule drugs using a conjugation technique. The company's technology increases a drug's therapeutic index by conce…

Articles about SynDevRx's Unattributed Round: